How to Manage Semaglutide Side Effects, From Nausea to Constipation
A sourced guide to semaglutide side effects (nausea, constipation, fatigue, gallbladder, pancreatitis), with practical management steps and red flags.
By Ruth Calder, Enforcement Editor
Our methodology sets out how these guides get researched and kept current.
Looking for a provider? Our 2026 comparison of the leading GLP-1 telehealth sellers is a click away.
Semaglutide Drug Guide →Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Semaglutide is highly effective for weight loss and type 2 diabetes, but like any medication that produces meaningful biological change, it comes with side effects. Most are manageable and a few are serious. Knowing which is which, and what to do about each, can turn a frustrating treatment experience into a successful one.
Below are the notable semaglutide side effects, the clinical evidence behind each, and practical management strategies that work in real-world patient experience. Every medical claim is sourced. If you're experiencing severe symptoms now and need urgent guidance, contact your prescriber or a 24/7 nurse line; this article is education, not medical advice.
For a broader picture of the medication itself, see our semaglutide drug guide. For dose-by-dose expectations, read our semaglutide dosing schedule.
Key Takeaways
- 80% of patients experience some GI side effect at some point during titration; most are mild.
- Nausea is the most common and almost always improves within 2 weeks of each dose increase.
- Constipation is more under-reported than nausea but easier to manage with hydration and fiber.
- Pancreatitis and gallbladder disease are rare but serious, so know the warning signs.
- Slow titration is the single most effective prevention strategy for almost every side effect.
- Discontinuation due to gastrointestinal side effects in the STEP-1 trial was 4.5%, vs 0.8% on placebo.
The Most Common Side Effects (and How to Manage Them)
Nausea
Nausea is the single most common semaglutide side effect, reported by ~44% of patients in STEP-1. It usually peaks 24–72 hours after an injection, especially after a dose increase, and improves as your body acclimates over the following 1–2 weeks.
Why it happens: Semaglutide slows the rate at which your stomach empties. A stomach that holds food longer makes you feel full, which helps weight loss. The same fullness can easily tip into nausea, usually after a large or fatty meal.
Management:
- Eat smaller, more frequent meals (4–6 small meals instead of 3 large ones)
- Avoid greasy, fried, or very high-fat foods on injection day and the day after
- Slow down; chewing thoroughly matters more on semaglutide than off it
- Stay hydrated; sip clear fluids throughout the day
- Ginger (real ginger, ginger tea, or ginger chews) is mildly effective
- If symptoms are severe, your prescriber can prescribe ondansetron (Zofran) or promethazine, both common in GLP-1 telehealth practice
When to call your prescriber: Nausea that prevents you from staying hydrated, vomiting more than twice a week, weight loss faster than 2.5 lb/week consistently, or any sign of dehydration (dark urine, dizziness, fatigue beyond normal).
Constipation
Constipation was reported by ~24% of STEP-1 patients and is probably under-reported. It comes from two directions at once: the stomach empties more slowly, and less food is going in.
Management:
- Increase water intake significantly (aim for 80+ oz per day)
- Add fiber gradually (psyllium husk, ground flaxseed, vegetables)
- Magnesium citrate (200–400 mg at bedtime) is well-tolerated and effective
- Walk or move daily; physical activity helps GI motility
- If constipation persists more than 5 days, discuss laxatives with your prescriber
Vomiting
Vomiting was reported by ~24% of patients in STEP-1. It is usually associated with eating too much, eating too fast, or eating high-fat foods after a recent injection.
Management:
- Put the fork down the moment fullness registers. This takes practice, because semaglutide changes what fullness feels like
- Leave alcohol alone, above all in the 48 hours following an injection
- On injection day, skip anything fried, fatty or heavily spiced
- Sit upright for 30+ minutes after meals
- If vomiting is frequent (>2x/week), ask your prescriber to slow your titration or hold your current dose
Diarrhea
Diarrhea was reported by ~30% of STEP-1 patients and is usually mild and self-limiting.
Management:
- Stay hydrated (electrolyte beverages, broth, oral rehydration solutions)
- Avoid dairy, caffeine, and high-sugar foods until symptoms resolve
- The BRAT diet (bananas, rice, applesauce, toast) is gentle
- If diarrhea persists more than 3 days or is bloody, contact your prescriber
Fatigue
Fatigue gets less attention than GI symptoms, but patients commonly report it in real-world surveys. Three causes account for most of it: dehydration, a large drop in calories because you are simply eating less, or low blood sugar, especially in people also taking insulin or sulfonylureas.
Management:
- Make sure you're hitting your protein target (0.8–1.0 g per pound of goal body weight)
- Stay hydrated
- If you're diabetic and on other glucose-lowering medications, discuss with your prescriber whether dosages need adjustment
- Sleep 7–9 hours per night
- Light exercise (walking) helps fatigue, counterintuitively
Headache
Headache was reported by ~14% of STEP-1 patients and is often associated with dehydration or low blood sugar.
Management:
- Hydration first
- Eat regularly even when not hungry
- Standard OTC pain relievers (acetaminophen, ibuprofen) are fine for occasional use
Less Common but Important Side Effects
Injection site reactions
Itching, swelling or mild redness where you injected is common, and it settles without treatment. Rotate injection sites (abdomen, thigh, upper arm) and avoid injecting through clothing.
Hair thinning
Some patients report hair shedding during rapid weight loss on semaglutide. This is usually due to telogen effluvium (a stress response to rapid weight loss, not a direct drug effect). It typically resolves within 6–12 months. Adequate protein and biotin intake may help.
Mood changes
The FDA reviewed reports of suicidal thoughts in GLP-1 patients and found no increased risk. In January 2026 it asked for the suicidal-behavior warning to be removed from the Wegovy, Zepbound and Saxenda labels. Still, if you experience new depression or anxiety while on semaglutide, discuss with your prescriber.
Hypoglycemia
Low blood sugar is rare in non-diabetic patients on semaglutide. It's more common in diabetes patients also taking insulin or sulfonylureas, where dose adjustments may be needed.
Serious (Rare) Side Effects: Know the Warning Signs
These are uncommon but require immediate medical attention.
Pancreatitis
The FDA has flagged pancreatitis as a potential risk for all GLP-1 drugs, though large observational studies in 2023–2024 have shown the absolute risk is small. If pancreatitis is suspected, the Wegovy label says to stop the drug and start appropriate management.
Warning signs:
- Severe abdominal pain that radiates to the back
- Pain that worsens after eating
- Nausea and vomiting that doesn't resolve
- Fever, rapid pulse
What to do: Stop the medication and seek immediate medical evaluation.
Gallbladder disease
Rapid weight loss of any kind (not just GLP-1-induced) increases the risk of gallstones and gallbladder inflammation. STEP-1 reported gallbladder-related events in about 2.6% of semaglutide patients vs 1.2% of placebo over 68 weeks.
Warning signs:
- Sharp pain high on the right of the abdomen, typically after a fatty meal
- That pain reaching through into the back, or the right shoulder
- Nausea, vomiting, fever
- Yellowing of skin or eyes (jaundice, which is urgent)
What to do: Contact your prescriber. Many patients can continue semaglutide after gallbladder evaluation; some require surgical intervention.
Acute kidney injury
Severe dehydration from prolonged nausea and vomiting can cause acute kidney injury. It is mostly preventable: keep your fluids up, and call your prescriber the moment you cannot keep them down.
Thyroid C-cell tumors
The boxed warning on semaglutide concerns thyroid C-cell tumors seen in rodent studies. No human data has confirmed that risk, but the contraindication stands: semaglutide is not for anyone who has, or has a relative with, MTC (medullary thyroid carcinoma) or MEN2 (multiple endocrine neoplasia syndrome type 2).
Diabetic retinopathy complications
In patients with pre-existing diabetic retinopathy, rapid improvement in blood sugar from semaglutide can paradoxically worsen retinal disease in the short term. If you have diabetes and any history of eye disease, see an ophthalmologist before starting and during treatment.
Side Effects by Dose
In STEP-1, the percentage of patients reporting each common side effect at the 2.4 mg maintenance dose:
| Side effect | Semaglutide 2.4 mg | Placebo |
|---|---|---|
| Nausea | 44.2% | 17.4% |
| Diarrhea | 31.5% | 15.9% |
| Vomiting | 24.8% | 6.6% |
| Constipation | 23.4% | 9.5% |
| Headache | 14.4% | 13.0% |
| Fatigue | 11.2% | 4.4% |
| Dyspepsia | 9.2% | 2.6% |
Most symptoms were rated as mild to moderate. Only 4.5% of semaglutide patients discontinued because of gastrointestinal events vs 0.8% on placebo.
Slow Titration Is the Best Prevention
Every study and every clinician interview confirms the same finding: slow titration prevents most side effects. The standard 4-weeks-per-dose schedule exists for a reason. If you're struggling, ask your prescriber about extending each dose level to 6 or even 8 weeks.
Reputable GLP-1 telehealth providers make it easy to message your prescriber and request a dose hold or step-back. It is one of the most underrated features when comparing providers; our methodology explains how we evaluate each provider's clinical responsiveness.
For a complete week-by-week guide to what to expect at each dose level, read our semaglutide dosing schedule.
Day-to-day help with eating around nausea and constipation is easier to get when the plan includes it. Some compounded semaglutide sellers put coaching inside the monthly price: TMates, Metabolyz and TD Tele-Doc Weight Loss do, Elara Health and Wellness includes labs and a health coach, and Medsol RX includes a care coach.
Livea lists nutrition coaching, Vita Bella lists coaching among what its plan includes, and Fella Health offers health coaching to existing members while new signups are paused. Get Thin MD includes coaching as well.
When to Stop the Medication
Most side effects can be managed with patience, hydration, dietary adjustments, and dose modifications. But there are situations where stopping semaglutide is the right call:
- Confirmed pancreatitis
- Severe gallbladder disease requiring surgery
- Severe allergic reaction (rash, swelling, breathing difficulty)
- Pregnancy (the labels say to stop semaglutide two months or more before trying to conceive)
- Persistent inability to maintain adequate nutrition
- New diagnosis of medullary thyroid carcinoma or MEN2 in you or a first-degree relative
If you stop semaglutide, the appetite-suppressing effect wears off within a few weeks. In the STEP-1 extension, patients who stopped after 68 weeks had regained about two-thirds of what they had lost a year later. If you need to stop temporarily for a medical issue, talk to your prescriber about restarting at a lower dose to avoid re-experiencing initial titration symptoms.
Bottom Line
Most semaglutide side effects are mild, predictable, and manageable. Nausea and constipation are the big two; both respond well to dietary adjustments, hydration, and dose pacing. The serious side effects (pancreatitis, gallbladder disease, kidney injury) are rare but real, and patients should know the warning signs.
Two habits matter more than anything else for keeping side effects down: climb the dose slowly, and tell your prescriber what is actually happening. If you're working with a reputable telehealth provider, this is straightforward. If your provider doesn't make it easy to message a prescriber and request dose changes, that's a red flag. Our compounded semaglutide safety guide has more on choosing a provider with real medical oversight.
For more on the underlying drug, see our semaglutide drug guide. For the head-to-head with tirzepatide (which has a similar but slightly different side effect profile), read Semaglutide vs Tirzepatide.
Sources & methodology — as of October 2026
- 1.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 2.SUSTAIN-6 Trial — Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (Marso SP et al.)— New England Journal of Medicine.PMID: 27633186.
- 3.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 4.FDA Adverse Event Monitoring System (AEMS) Public Dashboard (formerly FAERS)— U.S. Food & Drug Administration.
- 5.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
Compare the sellers
Ready to compare GLP-1 providers?
Trust, support, availability, the medications carried and what they cost — we rank every major telehealth seller on all five, and refresh it each quarter. Nothing padded.
Semaglutide Drug Guide →Related guides
Semaglutide Dose Steps: What Each One Feels Like and How to Tolerate It
Week-by-week semaglutide titration chart, what to expect at each dose, side effect timing, and when to ask your prescriber to slow down or hold steady.
Compounded Semaglutide: Is It Safe? What to Know in 2026
A sourced guide to compounded semaglutide safety: FDA's stance, 503A vs 503B pharmacies, what to look for in a provider, and red flags to walk away from.
Semaglutide or Tirzepatide: Which Should You Start On?
Semaglutide against tirzepatide: efficacy from the STEP and SURMOUNT trials, side effects, cost, availability, and which one fits you.
Ozempic and Gallbladder Issues: What the Research Actually Shows
The elevated risk of gallbladder disease on GLP-1 drugs: what the JAMA meta-analysis found, why it happens, and who's at higher risk.
Read our methodology · affiliate disclosure · about us